Skip to content

National Survey on Gastroesophageal Reflux Disease (GERD) Patients

Evaluation of the Impact of Abdominal Fat on GERD Severity and GERD Frequency in General Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00695838
Acronym
LINEA
Enrollment
5084
Registered
2008-06-12
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2009-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Keywords

GERD symptoms- Waist circumference, Patients with symptomatic GERD

Brief summary

The purpose of this observational study is to assess the impact of abdominal fat on severity and frequency of GERD symptoms .

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female \> or = 18 years old * Patient with symptomatic GERD * Without PPI or H2 antagonist treatment during the 3 previous months * Agree to take part in this study

Exclusion criteria

* Pregnant women

Design outcomes

Primary

MeasureTime frame
Waist circumferenceOnce

Secondary

MeasureTime frame
Frequency of GERD symptomsOnce
GERD impact scaleOnce

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026